Condition: Neonatal Infection · Sponsor: Universitaire Ziekenhuizen KU Leuven
Vancomycin is already used for decades in neonates. However, there are remaining questions concerning vancomycin disposition in this population. The purpose of this study is first of all to perform a paired analysis of serum vancomycin concentrations using an immunoassay versus a reference liquid chromatography-tandem mass spectrometry method. Secondly, we aim to determine vancomycin protein binding and its covariates in neonates.
This description comes directly from the study's public registry record.
Anne Smits, MD · 003216341564 · anne.smits@uzleuven.be
Karel Allegaert, MD, PhD · 003216343210 · karel.allegaert@uzleuven.be
Always discuss trial participation with your own doctor first.
| UZ Leuven | Leuven, Vlaams-Brabant, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02096536